Mettler-Toledo International Inc. (NYSE:MTD) Shares Sold by Point72 Hong Kong Ltd

Point72 Hong Kong Ltd reduced its position in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 77.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 855 shares of the medical instruments supplier's stock after selling 3,011 shares during the period. Point72 Hong Kong Ltd's holdings in Mettler-Toledo International were worth $1,283,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. PineStone Asset Management Inc. boosted its holdings in Mettler-Toledo International by 127.4% in the 2nd quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier's stock valued at $362,855,000 after purchasing an additional 145,453 shares during the last quarter. Loomis Sayles & Co. L P increased its position in shares of Mettler-Toledo International by 1.8% during the 3rd quarter. Loomis Sayles & Co. L P now owns 209,902 shares of the medical instruments supplier's stock worth $314,790,000 after purchasing an additional 3,644 shares during the last quarter. TD Asset Management Inc raised its holdings in Mettler-Toledo International by 1.9% in the 2nd quarter. TD Asset Management Inc now owns 157,247 shares of the medical instruments supplier's stock valued at $219,767,000 after buying an additional 2,866 shares during the period. Massachusetts Financial Services Co. MA lifted its position in Mettler-Toledo International by 32.5% in the second quarter. Massachusetts Financial Services Co. MA now owns 142,944 shares of the medical instruments supplier's stock valued at $199,777,000 after buying an additional 35,048 shares during the last quarter. Finally, International Assets Investment Management LLC boosted its stake in Mettler-Toledo International by 149,870.0% during the third quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier's stock worth $134,946,000 after buying an additional 89,922 shares during the period. 95.07% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Mettler-Toledo International

In other news, Director Elisha W. Finney sold 76 shares of the stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the transaction, the director now directly owns 240 shares of the company's stock, valued at approximately $314,820. This represents a 24.05 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 1.94% of the stock is currently owned by corporate insiders.

Mettler-Toledo International Stock Down 0.1 %

NYSE:MTD traded down $1.83 during trading hours on Monday, reaching $1,249.37. 37,253 shares of the company's stock were exchanged, compared to its average volume of 136,447. The firm has a market capitalization of $26.37 billion, a price-to-earnings ratio of 33.49, a P/E/G ratio of 4.13 and a beta of 1.16. Mettler-Toledo International Inc. has a 1-year low of $1,068.33 and a 1-year high of $1,546.93. The company has a 50-day moving average of $1,345.17 and a 200 day moving average of $1,392.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The firm had revenue of $954.54 million for the quarter, compared to analysts' expectations of $941.93 million. Research analysts forecast that Mettler-Toledo International Inc. will post 40.42 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on MTD. Evercore ISI upped their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an "in-line" rating in a report on Tuesday, October 1st. Wells Fargo & Company decreased their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an "equal weight" rating on the stock in a research note on Monday, November 11th. Robert W. Baird dropped their price objective on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a "neutral" rating for the company in a research note on Monday, November 11th. Stifel Nicolaus lowered their target price on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a "buy" rating for the company in a report on Monday, November 11th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a "neutral" rating in a research note on Monday, August 5th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, Mettler-Toledo International currently has a consensus rating of "Hold" and a consensus target price of $1,338.75.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.